LILRB4通过STAT3-PFKFB1通路调节多发性骨髓瘤的发展
Li Xie1, Chiqi Chen1, Tinghua Zhang1
1Hongqiao International Institute of Medicine, Shanghai Tongren Hospital, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Faculty of Basic Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China.
Cell death & disease
|July 18, 2024
概括
白细胞免疫球蛋白样受体B4 (LILRB4) 在多发性骨髓瘤中表达高,阻碍了免疫治疗. 针对LILRB4显示出作为多发性骨髓瘤患者的新治疗策略的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 多发性骨髓瘤 (MM) 对免疫疗法表现出不同的反应,需要新的治疗点.
- 现有的免疫疗法对所有MM患者来说都不够,有些人仍然没有反应或复发.
研究的目的:
- 研究白细胞免疫球蛋白样受体B4 (LILRB4) 在多发性骨髓瘤进展中的作用.
- 探索LILRB4作为增强MM免疫疗法的潜在治疗标.
主要方法:
- 在MM细胞系和患者样本中分析LILRB4表达.
- 在体外和体外对LILRB4进行淘汰,以评估其对MM细胞生长的影响.
- 研究涉及IKZF1,STAT3和PFKFB1通路的分子机制.
- 对LILRB4阻断抗体治疗潜力的评估.
主要成果:
- 在MM细胞系和患者样本中,LILRB4表达显著升高.
- 高LILRB4表达与MM患者的整体存活率相反相关.
- 在体外和体内,LILRB4敲击抑制了MM细胞的增殖.
- IKZF1被确定为LILRB4的交换激活器,这反过来又激活了STAT3-PFKFB1信号,促进了MM细胞的增殖.
- 用抗体阻止LILRB4信号传递抑制了MM的进展.
结论:
- LILRB4是MM细胞增殖和进展的关键驱动因素.
- 准LILRB4代表了对多发性骨髓瘤免疫疗法的有前途的新疗法策略.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
The JAK-STAT Signaling Pathway
8.8K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K
Negative Regulator Molecules
35.3K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.3K


